The Diabetes League is sounding the alarm now that there is a threat of a shortage of the drug ozempic. It is crucial for people with type 2 diabetes, so the League is calling on doctors to stop prescribing the drug to overweight people in the coming months. But the drug has already proven its usefulness with them too. Is such a call appropriate?
